These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 17690121)
1. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC; Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121 [TBL] [Abstract][Full Text] [Related]
2. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Migliori GB; Lange C; Centis R; Sotgiu G; Mütterlein R; Hoffmann H; Kliiman K; De Iaco G; Lauria FN; Richardson MD; Spanevello A; Cirillo DM; Eur Respir J; 2008 Jun; 31(6):1155-9. PubMed ID: 18515555 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data. Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052 [TBL] [Abstract][Full Text] [Related]
5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407 [TBL] [Abstract][Full Text] [Related]
8. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions. Prasad R Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336 [TBL] [Abstract][Full Text] [Related]
9. Problems of multidrug- and extensively drug-resistant TB. Drug Ther Bull; 2012 Feb; 50(2):21-4. PubMed ID: 22329954 [TBL] [Abstract][Full Text] [Related]
10. New treatment options for multidrug-resistant tuberculosis. Field SK; Fisher D; Jarand JM; Cowie RL Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676 [TBL] [Abstract][Full Text] [Related]
11. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Chang KC; Yew WW Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408 [TBL] [Abstract][Full Text] [Related]
12. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157 [TBL] [Abstract][Full Text] [Related]
13. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes. Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226 [TBL] [Abstract][Full Text] [Related]
14. Extensively drug-resistant tuberculosis: current challenges and threats. Jain A; Mondal R FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439 [TBL] [Abstract][Full Text] [Related]
15. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects. Yew WW Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001 [TBL] [Abstract][Full Text] [Related]
16. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007. Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D; Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741 [TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959 [TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]